PACB (pacb.com) Net Income

Official company branding of pacb.com (PACB)

The price action of Pacific Biosciences (PACB) helps assess the efficiency of the DNA sequencing systems developer, where profit reached -0.13. The business relies on the humanitarian status of biomedicine, which minimizes external political threats. Simultaneously, Pacific Biosciences (PACB) is implementing an eco-friendly approach, reducing the use of plastics and aggressive chemicals in laboratories to mitigate environmental impact.

PACB Pacific Biosciences of California, Inc. Net Profit (07/04/2022 - 10/31/2026)

Financial and market metric breakdowns for PacBio (PACB)

- market value and analyst target forecast:
Stock Price PacBio Corp|PACB - Analyst Consensus Forecast
- business market valuation indicators:
Market Valuation PacBio Corp|PACB - Enterprise Value
- company book value details:
Net Assets per Share PacBio|PACB - Book Capitalization|Market Capitalization to Net Assets pacb.com|PACB - Company Total Assets
- debt burden and liquidity indicators:
Total Debt to Capital Coefficient Pacific Biosciences|PACB - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Pacific Biosciences of California, Inc.|PACB - Company Total Debt|Debt to Net Assets Ratio PacBio Corp|PACB - Company Long-Term Debts|Company Short-Term Debt PacBio|Interim Coverage Ratio pacb.com
- earnings and multiples data:
PACB - Company Net Income
Summary company analysis:PacBio Corp (PACB)
Mass-produced product of Pacific Biosciences of California

This indicator reflects the market consensus regarding the business's operational efficiency over time. The metric measures the net financial result after deducting all operating expenses. By analyzing the company's profit, investors assess management's ability to generate cash flow. For Pacific Biosciences (PACB), this figure is critical due to the pricing battle with sequencing leaders. The necessity of providing discounts to laboratories directly limits the growth of this profit.

Direct competitors

Tempus AI (TEM) - Net Profit|QGEN (Qiagen N.V.) - Net Profit|Net Income ionispharma.com (IONS)|Net Profit RGEN|Net Financial Result Avidity Biosciences Inc|Net Profit CRSP (CRISPR Therapeutics Corp)|WGS (GeneDx Corp) - Profit After Tax|Ultragenyx Pharmaceutical - Net Profit|Net Financial Result beamtx.com BEAM|SRPT: Net Profit|Net Income Twist Bioscience Inc|Net Income TXG|NTLA: Final Profit|Net Profit STOK|Company Net Income BLFS (biolifesolutions.com)|Net Profit WVE (Wave Life Sciences Ltd.)|Net Financial Result Maze Therapeutics, Inc. (MAZE)|SION - Company Net Income|Company Net Income Prime Medicine Bio|Taysha Gene Therapies (TSHA) - Company Net Income|QURE - Net Financial Result|MGTX (MeiraGTx) - Net Profit|Net Income REGENXBIO Inc (RGNX)|Net Profit SLDB|Net Financial Result Ocugen Pharma|Net Profit BNTC (Benitec Biopharma Inc.)|designtx.com (DSGN) - Company Net Income|RCKT - Company Net Income|FDMT (4DMT) - Company Profit|LXEO: Net Profit|Net Income Korro Bio|EDIT (Editas Medicine, Inc.) - Net Profit|Company Net Income silence-therapeutics.com SLN|Company Net Income ProQR Therapeutics N.V. (PRQR)|Net Financial Result codexis.com|Company Net Income Sangamo SGMO|NAUT (Nautilus Biotechnology, Inc.) - Profit After Tax|Metagenomi, Inc. - Net Profit|DTIL - Net Profit|GBIO: Net Profit|Net Income Boundless Bio Inc.|XCUR (Exicure Inc.) - Net Profit|Company Net Income IMNN|Net Profit PHIO|mustangbio.com - Company Profit|Company Net Income TransCode Therapeutics, Inc. RNAZ|BNGO: Company Profit|Applied DNA - Net Profit|BLUE - Net Profit|immunoprecise.com (IPA) - Company Net Income|Profit After Tax OMGA (omegatherapeutics.com)|OMIC (Singular Genomics) - Net Profit|Net Profit Regulus Therapeutics, Inc.|Net Profit SYRS|Net Income Telesis Bio, Inc TBIO|Net Profit TCON (TRACON Pharmaceuticals)|Net Financial Result unitybiotechnology.com (UBX)